Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.89 USD | +0.82% | -22.13% | -75.13% |
May. 10 | Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating | MT |
May. 10 | Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating | MT |
Financials (USD)
Sales 2024 * | 325M | Sales 2025 * | 249M | Capitalization | 204M |
---|---|---|---|---|---|
Net income 2024 * | -254M | Net income 2025 * | -36M | EV / Sales 2024 * | 1.07 x |
Net Debt 2024 * | 144M | Net Debt 2025 * | 133M | EV / Sales 2025 * | 1.35 x |
P/E ratio 2024 * |
-0.82
x | P/E ratio 2025 * |
-3.72
x | Employees | 1,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.18% |
Latest transcript on Cerence Inc.
1 day | +0.82% | ||
1 week | -22.13% | ||
Current month | -46.32% | ||
1 month | -56.55% | ||
3 months | -68.59% | ||
6 months | -72.44% | ||
Current year | -75.13% |
Managers | Title | Age | Since |
---|---|---|---|
Stefan Ortmanns
CEO | Chief Executive Officer | 60 | 19-09-30 |
Iqbal Arshad
CTO | Chief Tech/Sci/R&D Officer | 52 | 23-05-01 |
Thomas Beaudoin
BRD | Director/Board Member | 70 | 19-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sanjay Jha
BRD | Director/Board Member | 60 | 19-09-30 |
Al Nietzel
BRD | Director/Board Member | 62 | 19-09-30 |
Arun Sarin
CHM | Chairman | 68 | 19-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.30% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 4.89 | +0.82% | 4,063,894 |
24-05-15 | 4.85 | -2.81% | 1,730,776 |
24-05-14 | 4.99 | -2.16% | 5,374,140 |
24-05-13 | 5.1 | -4.67% | 2,928,199 |
24-05-10 | 5.35 | -14.81% | 3,728,166 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.13% | 204M | |
+11.94% | 3,129B | |
+10.56% | 86.84B | |
+6.08% | 78.63B | |
-14.73% | 53.93B | |
+26.21% | 48.21B | |
-23.40% | 47.43B | |
+29.50% | 45.58B | |
+76.40% | 41.03B | |
-9.24% | 24.92B |
- Stock Market
- Equities
- CRNC Stock